Atlas FDA

HEPARIN-INDUCED EXTRACORPOREAL LIPOPROTEIN PRECIPITATION (H.E.L.P.) FUTURA APHERESIS SYSTEM

FDA premarket approval P940016/S014 · decided 2012-01-13

Approval details

PMA number
P940016
Supplement
S014
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
HEPARIN-INDUCED EXTRACORPOREAL LIPOPROTEIN PRECIPITATION (H.E.L.P.) FUTURA APHERESIS SYSTEM
Generic name
Lipoprotein, low density, removal
Applicant
B. Braun Avitum AG
Date received
2011-07-19
Decision date
2012-01-13
Days to decision
178 days
Decision code
APPR
Product code
MMY
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Melsungen
Statement
APPROVAL FOR A CHANGE IN THE POTTING RESIN USED TO ANCHOR THE MEMBRANES OF THE HEPARIN ADSORBER AND THE PLASMAFILTER HAEMOSELECT COMPONENTS OF THE SYSTEM.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Diacap Pro Dialyzer (K170574)B. Braun Avitum AG2017-08-11
xevonta dialyzer (K143482)B. Braun Avitum AG2016-03-01
SOLCART B (K102194)B. Braun Avitum AG2011-04-25
DIACAP POLYSULFONE HIFLO 23 HEMODILAYZER , MODEL 72036811 (K100334)B. Braun Avitum AG2010-04-22
DIALOG WITH ADIMEA OPTION (K083460)B. Braun Avitum AG2010-02-18